JULIUS CLINICAL – SCIENCE CONTRACT RESEARCH ORGANISATION
GLOBAL & FOCUSED
Julius Clinical is the Contract Research Organisation (CRO) that manages global clinical drug trials that will have a major impact on medicine and make a real difference to people’s lives around the world. Our unique combination of scientific leadership and operational excellence ensures that the trial data is of the highest quality.
We specialise in distinct therapeutic areas including Cardio Metabolic, Infectious diseases and Immunology and Brain. We can offer a full-service proposal or separate functional services as required.
ENT CLINICAL
The academic clinical research organisation with the expertise to support your clinical development program in the hearing field.
RWE & RWD
Julius Clinical’s RWE specialists and data scientists are academic thought leaders in RWE, RWD and the creation of tailor-made studies.
I/I
Julius Clinical’s experience in infectious disease research is epitomized by the CAPiTA study; the largest vaccine trial worldwide.
CARDIO METABOLIC
Julius Clinical has a strong track record of expertise and performance in the field of Cardiovascular diseases and the related field Metabolic diseases.
BRAIN
Julius Clinical is active in the field of diseases affecting the Brain, managing trials involving patients with a range of neurological or psychiatric disorders.
Non-alcoholic steatohepatitis, a form of fatty liver disease characterized by inflammation and liver fibrosis, is associated with obesity and has a worldwide prevalence of 1.7 billion people.
An international team of researchers has identified the CNNM4 protein as a key regulator of magnesium in the liver and potential therapeutic target for non-alcoholic fatty liver disease, according to a study published in the Journal of Hepatology.
Read the full article here: https://lnkd.in/dGNzFbf
More information about NASH? Visit NASH Clinical: https://lnkd.in/gNuMz7j or get in contact with Martin Czakon
#Nonalcoholicsteatohepatitise #NASH #fattyliverdisease